Sunday, April 09, 2017 7:49:54 PM
Any company not seeking to get FDA approved drugs in the long term are risking being left out.
As far as saying marijuana is a harmless drug is completey untrue. All you have to do is google studies that show there are those at risk for psychotic reactions if they are genetically predisposed. That's part of the reason why most companies are staying away from drugs taken orally. It's little known but there were a couple of companies who stopped Phase III clinical trials 20 years ago because of the psychoactive effects. I believe one of them was Valeant.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM